In some embodiments, the otic formulation or composition comprises between about 0.10% to about 10% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Retrieved 31 October 2017
Maintained properties of aged dental pulp stem cells for superior periodontal tissue regeneration
BPC-157 (pentadecapeptide, 10mg) focuses on angiogenesis and growth factor signalling, while TB-500 (Thymosin Beta-4 analogue, 10mg) targets actin-binding and cellular motility
In addition to its potential influence on sleep patterns, DSIP appears to influence levels of corticotropin, inhibit the production of somatostatin, reduce stress hormone secretion, maintain normal blood pressure, alter sleep patterns and also may impact pain perception